![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
No Clinically Significant Pharmacokinetic Interaction Between Sovaprevir and ACH-3102 in Healthy Volunteers
|
|
|
Reported by Jules Levin
EASL 2013 April 24-28 Amsterdam
James Hui1, Lisa Robarge1, Heather Robison1, Hetal S. Kocinsky1, Milind Deshpande1
1Achillion Pharmaceuticals, Inc., New Haven, CT
![EASL1.gif](../images/050913/050913-11/EASL1.gif)
![EASL2.gif](../images/050913/050913-11/EASL2.gif)
![EASL3.gif](../images/050913/050913-11/EASL3.gif)
![EASL4.gif](../images/050913/050913-11/EASL4.gif)
![EASL5.gif](../images/050913/050913-11/EASL5.gif)
![EASL6.gif](../images/050913/050913-11/EASL6.gif)
![EASL7.gif](../images/050913/050913-11/EASL7.gif)
![EASL8.gif](../images/050913/050913-11/EASL8.gif)
![EASL9.gif](../images/050913/050913-11/EASL9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|